Category archives: Generics

What is it? Proton therapy | Proton vs. radiation therapy | Proton therapy Uses | With other therapies | Proton therapy Risks | What to expect Proton therapy | Takeaway Proton therapy

What happens if chemotherapy does not work? Radiation therapy | Immunotherapy | Hormone therapy | Targeted therapy | Making a decision | Outlook | Takeaway

The enforcement by the drug regulator will not be easy given the shortage of drug inspectors {Taj Life Sciences} Generic Drug Division} Prime Minister Narendra Modi wants to defeat the doctor-pharmaceutical company nexus and make medicines affordable by making it compulsory to prescribe drugs in the generic name. But, the…

Despite lower price of generic imatinib, overall costs for chronic myeloid leukemia remain high ORLANDO ? The price of generic imatinib has decreased substantially in the United States over the past 2 years, according to a speaker at ASH Annual Meeting and Exposition. The decline comes after steep increases in…

Women?s Poor health condition in India: There?s lack of awareness about women?s health in India, mostly due to the taboos and superstitions associated with female genital hygiene and menstruation. Every 8 minutes, an Indian woman dies due to cervical cancer. Statistics state that this is the second-most common cancer among…

Another Record Year for Generic Drug Approvals {Taj Life Sciences}: [Generic Competition] For each of the last five years, the US Food and Drug Administration (FDA) has set generic drug approval records, but questions have lingered on whether these high approval numbers are translating into competition. FY 2019 figures show…

Fifteen years after it rose and went limp, the biotech sector saw a bull run of sorts In 2010, an unusual protest erupted over a still negotiated and secret free trade agreement between India and the European Union. Protesters were people living with HIV/AIDS and cancer. They saw a threat…

WHO signs MOU with International Generic and Biosimilar Medicines Association to promote access Full access to medicines is hampered by a variety of factors. Two important barriers are high prices and regulatory issues such as long lag times in bringing medicines to market. To address these issues, Dr Tedros Adhanom…

WHAT IS PHARMA PATENTING: A JUDICIAL APPROACH FROM {TAJ PHARMA INDIA} BRAND INFRINGEMENT ?Affluent societies are spending vast sums of money understandably on the search for new products and processes to alleviate suffering and to prolong life. In the process, drug manufactures have become a powerful industry. My idea of…